- Home
- AMPY vs GNLX Comparison
AMPY vs GNLX Comparison
Compare AMPY & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- GNLX
- Stock Information
- Founded
- AMPY 2011
- GNLX 2001
- Country
- AMPY United States
- GNLX United States
- Employees
- AMPY N/A
- GNLX N/A
- Industry
- AMPY Oil & Gas Production
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- GNLX Health Care
- Exchange
- AMPY Nasdaq
- GNLX Nasdaq
- Market Cap
- AMPY 152.1M
- GNLX 128.0M
- IPO Year
- AMPY 2011
- GNLX 2023
- Fundamental
- Price
- AMPY $4.12
- GNLX $3.56
- Analyst Decision
- AMPY Strong Buy
- GNLX Strong Buy
- Analyst Count
- AMPY 2
- GNLX 5
- Target Price
- AMPY $10.25
- GNLX $16.20
- AVG Volume (30 Days)
- AMPY 801.1K
- GNLX 116.8K
- Earning Date
- AMPY 08-06-2025
- GNLX 08-07-2025
- Dividend Yield
- AMPY N/A
- GNLX N/A
- EPS Growth
- AMPY N/A
- GNLX N/A
- EPS
- AMPY 0.38
- GNLX N/A
- Revenue
- AMPY $279,289,100.00
- GNLX N/A
- Revenue This Year
- AMPY $1.19
- GNLX N/A
- Revenue Next Year
- AMPY N/A
- GNLX N/A
- P/E Ratio
- AMPY $10.97
- GNLX N/A
- Revenue Growth
- AMPY N/A
- GNLX N/A
- 52 Week Low
- AMPY $2.27
- GNLX $1.95
- 52 Week High
- AMPY $7.35
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- AMPY 64.14
- GNLX 57.35
- Support Level
- AMPY $3.41
- GNLX $3.03
- Resistance Level
- AMPY $3.98
- GNLX $3.50
- Average True Range (ATR)
- AMPY 0.21
- GNLX 0.26
- MACD
- AMPY 0.02
- GNLX -0.02
- Stochastic Oscillator
- AMPY 97.92
- GNLX 79.10
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.